These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36335759)

  • 1. Airway anomalies in patients with 22q11.2 deletion syndrome: A scoping review.
    Hankey PB; Ghulmiyyah J; Yeh HW; Tracy M; Arganbright J
    Int J Pediatr Otorhinolaryngol; 2022 Dec; 163():111373. PubMed ID: 36335759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway Anomalies in Patients With 22q11.2 Deletion Syndrome: A 5-Year Review.
    Jones JW; Tracy M; Perryman M; Arganbright JM
    Ann Otol Rhinol Laryngol; 2018 Jun; 127(6):384-389. PubMed ID: 29732908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of lower airway anomalies in children with Down syndrome compared to controls.
    De Lausnay M; Verhulst S; Boel L; Wojciechowski M; Boudewyns A; Van Hoorenbeeck K
    Pediatr Pulmonol; 2020 May; 55(5):1259-1263. PubMed ID: 32203641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of airway abnormalities with 22q11.2 deletion syndrome.
    Sacca R; Zur KB; Crowley TB; Zackai EH; Valverde KD; McDonald-McGinn DM
    Int J Pediatr Otorhinolaryngol; 2017 May; 96():11-14. PubMed ID: 28390597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital respiratory tract disorders in 22q11.2 deletion syndrome.
    Verheij E; Speleman L; Mink van der Molen AB; Thomeer HGXM
    Int J Pediatr Otorhinolaryngol; 2018 Jan; 104():1-4. PubMed ID: 29287846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthopaedic manifestations within the 22q11.2 Deletion syndrome: A systematic review.
    Homans JF; Tromp IN; Colo D; Schlösser TPC; Kruyt MC; Deeney VFX; Crowley TB; McDonald-McGinn DM; Castelein RM
    Am J Med Genet A; 2018 Oct; 176(10):2104-2120. PubMed ID: 29159873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid gland and carotid artery anomalies in 22q11.2 deletion syndromes.
    de Almeida JR; James AL; Papsin BC; Weksburg R; Clark H; Blaser S
    Laryngoscope; 2009 Aug; 119(8):1495-500. PubMed ID: 19507237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized Epilepsy and Myoclonic Seizures in 22q11.2 Deletion Syndrome.
    Strehlow V; Swinkels ME; Thomas RH; Rapps N; Syrbe S; Dorn T; Lemke JR
    Mol Syndromol; 2016 Sep; 7(4):239-246. PubMed ID: 27781034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hearing loss and clinical otologic manifestations in patients with 22q11.2 deletion syndrome: A literature review.
    Verheij E; Derks LSM; Stegeman I; Thomeer HGXM
    Clin Otolaryngol; 2017 Dec; 42(6):1319-1328. PubMed ID: 28322025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital and iatrogenic laryngeal and vocal abnormalities in patients with 22q11.2 deletion.
    Ebert B; Sidman J; Morrell N; Roby BB
    Int J Pediatr Otorhinolaryngol; 2018 Jun; 109():17-20. PubMed ID: 29728175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden.
    Oskarsdóttir S; Vujic M; Fasth A
    Arch Dis Child; 2004 Feb; 89(2):148-51. PubMed ID: 14736631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Ear Anomalies and Hearing Loss Among Children With 22q11.2 Deletion Syndrome.
    Wu SS; Mahomva C; Sawaf T; Reinshagen KL; Karakasis C; Cohen MS; Hadford S; Anne S
    Otolaryngol Head Neck Surg; 2023 Apr; 168(4):856-861. PubMed ID: 35439096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtypes in 22q11.2 deletion syndrome associated with behaviour and neurofacial morphology.
    Sinderberry B; Brown S; Hammond P; Stevens AF; Schall U; Murphy DG; Murphy KC; Campbell LE
    Res Dev Disabil; 2013 Jan; 34(1):116-25. PubMed ID: 22940165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hearing loss in children with 22q11.2 deletion syndrome.
    Jiramongkolchai P; Kumar MS; Chinnadurai S; Wootten CT; Goudy SL
    Int J Pediatr Otorhinolaryngol; 2016 Aug; 87():130-3. PubMed ID: 27368459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camptodactyly and the 22q11.2 deletion syndrome.
    Couser NL; Pande CK; Walsh JM; Tepperberg J; Aylsworth AS
    Am J Med Genet A; 2017 Feb; 173(2):515-518. PubMed ID: 27792854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low prevalence of substance use in people with 22q11.2 deletion syndrome.
    Vingerhoets C; van Oudenaren MJF; Bloemen OJN; Boot E; van Duin EDA; Evers LJM; Fiksinski AM; Breetvelt EJ; Palmer LD; Vergaelen E; Vogels A; Meijer C; Booij J; ; de Haan L; Swillen A; Vorstman JAS; Bassett AS; van Amelsvoort TAMJ
    Br J Psychiatry; 2019 Nov; 215(5):661-667. PubMed ID: 30604657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
    Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
    Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain microstructural abnormalities in 22q11.2 deletion syndrome: A systematic review of diffusion tensor imaging studies.
    Momtazmanesh S; Aarabi MH; Sanjari Moghaddam H; Delavari F; Shafie M; Abbasi-Feijani F; Cattarinussi G; Sambataro F
    Eur Neuropsychopharmacol; 2021 Nov; 52():96-135. PubMed ID: 34358796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.